Smiths ambulatory infusion system gains US clearance
31 March 2008
Smiths Medical has received US clearance for its CADD-Solis
ambulatory infusion system, a clinically and technologically advanced
ambulatory infusion platform that enhances patient safety and
personalised care for pain management patients.
Ambulatory infusion systems administer pain management medications,
including narcotics, via a variety of delivery routes including
intravenous and epidural. These devices have safeguards such as safety
software and intuitive programming options to help clinicians care for
their pain management patients.
The CADD-Solis system includes ambulatory infusion pump, medication
safety software, medication cassette reservoirs and administration sets.
“Improving patient safety and the quality of care is our first
priority,” said Jim Stitt, President of Smiths Medical. “By involving
both clinicians and the Human Factors Engineering team at the University
Health Network in Toronto in all phases of the development process, we
strove to design a safe, easy-to-use system that brings exceptional
value in helping hospitals reduce the risk of programming medication
errors while providing better patient care management.”